Biotechnology Articles on Seeking Alpha © seekingalpha.com. Use of this feed is limited to personal, non-commercial use and is governed by Seeking Alpha's Terms of Use (https://about.seekingalpha.com/terms). Publishing this feed for public or commercial use and/or misrepresentation by a third party is prohibited. SeekingAlpha.com https://seekingalpha.com Monte Rosa: Initiating Coverage With A Buy On Degrader Platform Potential https://seekingalpha.com/article/4914371-monte-rosa-initiating-coverage-with-a-buy-on-degrader-platform-potential?source=feed_tag_biotechnology 4914371 Thu, 11 Jun 2026 18:49:21 -0400 ARVN CCCC KYMR BMY NVS NVS:CA NVSEF GLUE Edmund Ingham Amgen hires Duke research organization to save Tavneos from market removal https://seekingalpha.com/news/4602811-amgen-hires-duke-research-organization-save-tavneos-market-removal?source=feed_tag_biotechnology 4602811 Thu, 11 Jun 2026 18:02:01 -0400 AMGN Ascendis boasts of long-term Yorvipath data for hypoparathyroidism https://seekingalpha.com/news/4602771-ascendis-boasts-long-term-yorvipath-data-hypoparathyroidism?source=feed_tag_biotechnology 4602771 Thu, 11 Jun 2026 16:31:08 -0400 ASND Nuvalent: 'Hold' On GlaxoSmithKline Acquisition For Selective Tyrosine Kinase Inhibitors https://seekingalpha.com/article/4914334-nuvalent-hold-on-glaxosmithkline-acquisition-for-selective-tyrosine-kinase-inhibitors?source=feed_tag_biotechnology 4914334 Thu, 11 Jun 2026 15:43:47 -0400 RHHBY PFE GLAXF PFE:CA RHHBF RHHVF ROCH:CA ROG:CA ZPFE:CA NUVL GSK Terry Chrisomalis AbbVie: Growth-Pharma Profile At A Value-Pharma Price https://seekingalpha.com/article/4914319-abbvie-growth-pharma-profile-at-a-value-pharma-price?source=feed_tag_biotechnology 4914319 Thu, 11 Jun 2026 14:54:57 -0400 ABBV ABBV:CA Himalayas Research Kymera, Monte Rosa among gainers as Novartis inks deal for molecular glue drugs https://seekingalpha.com/news/4602728-kymera-monte-rosa-gain-novartis-seek-molecular-glue-drugs?source=feed_tag_biotechnology 4602728 Thu, 11 Jun 2026 14:36:53 -0400 NVS NRIX KYMR GLUE GILD NVSEF Cullinan Therapeutics: Heading Toward Paydirt https://seekingalpha.com/article/4914254-cullinan-therapeutics-heading-toward-paydirt?source=feed_tag_biotechnology 4914254 Thu, 11 Jun 2026 11:41:04 -0400 CGEM Galzus Research Twist Bio favored at Piper despite wait-and-see approach for tools stocks https://seekingalpha.com/news/4602655-twist-bio-stock-new-overweight-piper?source=feed_tag_biotechnology 4602655 Thu, 11 Jun 2026 11:24:28 -0400 TWST DHR A WAT TMO TECH BMXMF DSRLF BMXXY Dianthus Therapeutics: Sanofi's CIPD Study Fail Poses Uncomfortable Questions https://seekingalpha.com/article/4914218-dianthus-therapeutics-sanofis-cipd-study-fail-poses-uncomfortable-questions?source=feed_tag_biotechnology 4914218 Thu, 11 Jun 2026 10:13:22 -0400 DNTH Edmund Ingham Aktis Oncology: Mini-Proteins With A Targeted Punch https://seekingalpha.com/article/4914209-aktis-oncology-mini-proteins-with-a-targeted-punch?source=feed_tag_biotechnology 4914209 Thu, 11 Jun 2026 10:02:13 -0400 AKTS Logan Richards Nurix Therapeutics Deal With Roche Is Worth Betting On https://seekingalpha.com/article/4914204-nurix-therapeutics-deal-with-roche-is-worth-betting-on?source=feed_tag_biotechnology 4914204 Thu, 11 Jun 2026 09:48:54 -0400 RHHBY RHHBF RHHVF ROCH:CA ROG:CA NRIX Myriam Alvarez Edesa Biotech announces $3.5M PIPE financing https://seekingalpha.com/news/4602601-edesa-biotech-announces-35m-pipe-financing?source=feed_tag_biotechnology 4602601 Thu, 11 Jun 2026 09:45:44 -0400 EDSA 60 Degrees Pharmaceuticals signs FSU deal to scale Australian chestnut extract https://seekingalpha.com/news/4602594-60-degrees-pharmaceuticals-sings-fsu-deal-to-scale-australian-chestnut-extract?source=feed_tag_biotechnology 4602594 Thu, 11 Jun 2026 09:22:42 -0400 SXTP Syndax Pharmaceuticals: The Duration Expansion Story Is Being Underpriced https://seekingalpha.com/article/4914182-syndax-pharmaceuticals-the-duration-expansion-story-is-being-underpriced?source=feed_tag_biotechnology 4914182 Thu, 11 Jun 2026 08:57:50 -0400 SNDX Equity Eagle Summit Therapeutics withdraws proposed securities offering citing market conditions https://seekingalpha.com/news/4602553-summit-therapeutics-withdraws-proposed-securities-offering-citing-market-conditions?source=feed_tag_biotechnology 4602553 Thu, 11 Jun 2026 08:21:09 -0400 SMMT Atossa Therapeutics prices up to $16.5M direct offering https://seekingalpha.com/news/4602550-atossa-therapeutics-prices-up-to-16_5m-direct-offering?source=feed_tag_biotechnology 4602550 Thu, 11 Jun 2026 08:19:56 -0400 ATOS Humacyte prices $50M public offering of common stock at $1.05/share https://seekingalpha.com/news/4602434-humacyte-prices-50m-public-offering-of-common-stock-at-105share?source=feed_tag_biotechnology 4602434 Thu, 11 Jun 2026 00:14:53 -0400 HUMA Viking Therapeutics: Drugs Are In The Pipeline, But Profitability Is Still Unproven https://seekingalpha.com/article/4913969-viking-therapeutics-drugs-are-in-the-pipeline-but-profitability-is-still-unproven?source=feed_tag_biotechnology 4913969 Wed, 10 Jun 2026 18:04:29 -0400 VKTX LLY NVO BCRX ABBV MDGL Ryan Canady Stocks to watch on Wednesday after-hours: ORCL, HUMA, ORGN https://seekingalpha.com/news/4602393-stocks-to-watch-on-wednesday-after-hours-orcl-huma-orgn?source=feed_tag_biotechnology 4602393 Wed, 10 Jun 2026 16:31:45 -0400 ORCL ORGN HUMA SP500 COMP:IND DJI Exicure receives Nasdaq notice over stockholders' equity requirement https://seekingalpha.com/news/4602371-exicure-receives-nasdaq-notice-over-stockholders-equity-requirement?source=feed_tag_biotechnology 4602371 Wed, 10 Jun 2026 16:09:51 -0400 XCUR